Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), an emerging growth company incorporated in the Cayman Islands, filed this Form 8-K on July 7, 2026. The report addresses the termination of a previously announced business combination.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Termination of Business Combination: On July 7, 2026, Aimei Health delivered a notice of termination to United Hydrogen Group Inc. and related entities.
- Agreement Status: The Business Combination Agreement, originally entered into on June 19, 2024, and amended on June 6, 2025, was terminated effective July 7, 2026, pursuant to Section 9.1(b).
- Outcome: The proposed business combination will not be consummated.
Guidance, Outlook, and Risks
The filing includes a press release (Exhibit 99.1) announcing the termination. No specific financial guidance, future outlook, or detailed risk factors are disclosed within the text of this 8-K. The primary contingency resolved by this filing is the cessation of the merger process with United Hydrogen.
Investor Verification Checklist
- Verify the terms of the termination notice delivered under Section 9.1(b) of the Business Combination Agreement.
- Review the press release (Exhibit 99.1) for any additional commentary on the reasons for termination.
- Confirm the status of any escrow accounts or deposits related to the failed transaction.
- Check for subsequent filings regarding the company's strategic direction post-termination.